Trial CTSU/NRG-BR005


A Phase II Trial Assessing the Accuracy of Tumor Bed Biopsies in Predicting Pathologic Response in Patients with Clinical/Radiologic Complete Response after Neoadjuvant Chemotherapy in Order to Explore the Feasibility of Breast Conserving Treatment without Surgery

Type: Diagnostic
Phase: Phase II
Status: Not Open (Closed)
Treatments:
Randomized: No
Defintions of terms and FAQ about clinical trials.
Trial Leaders/Researchers:  Alicia Terando, M.D.
Other Trial Staff:  Lusine Raddatz, D.M., Grace Facio, Coordinator, Margarita Carranza, D.M., America Casillas-Lopez, Coordinator, Alix Cohen, Coordinator

Staff may log in to see study documents.

Click here to see trial eligibility criteria and further details at ClinicalTrials.gov





For further information on a study, please contact the Clinical Investigation Support Office at (323) 865-0451, or clinical.trials@med.usc.edu.

To schedule a consultation with the hospital, please call our New Patient Referrals Office at (323) 865-3300.